Skip to content

Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)

Natural History of HPV Infections in Mid-Adult Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01295242
Acronym
WHIM
Enrollment
409
Registered
2011-02-14
Start date
2011-02-28
Completion date
2012-08-31
Last updated
2013-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillomavirus Infections

Keywords

HPV, Cervical Cancer

Brief summary

The purpose of this study is to determine rates of oral and genital human papillomavirus (HPV) infections, and look at risk factors for HPV infection in healthy mid-adult women.

Detailed description

The investigators propose a longitudinal study of 500 women in order to determine rates and risk factors for HPV infections in 30-50 year old women. Participants will be followed for 6 months and will be asked to complete online questionnaires on their health, sexual behavior, HPV vaccinations, and cervical cancer screening. The investigators will ask participants to self-collect monthly vaginal swab samples and self-collect 2 oral swab samples. Women will also be asked to provide 2 blood samples. All swab samples will be tested for type-specific HPV deoxyribonucleic acid (DNA) using a polymerase chain reaction (PCR)-based assay, blood samples will be tested for HPV antibodies.

Interventions

None listed

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* affiliated with the University of Washington (student, staff, faculty) * willing to self-collect vaginal samples at home for HPV testing * able to provide informed consent

Exclusion criteria

* pregnant * have had hysterectomy * serious medical condition which prevents completion of activities of daily living

Design outcomes

Primary

MeasureTime frame
Presence of type-specific HPV DNA in self-collected oral and vaginal swab samplesonce a month for 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026